Bs. Cooperman et al., ANTICHYMOTRYPSIN INTERACTION WITH CHYMOTRYPSIN - PARTITIONING OF THE COMPLEX, The Journal of biological chemistry, 268(31), 1993, pp. 23616-23625
The interactions of bovine pancreatic chymotrypsin (Chtr) and recombin
ant alpha1-antichymotrypsin (rACT) and rACT variants were studied by k
inetic and gel electrophoretic analyses, leading to the formulation of
a general kinetic scheme that accounts for all known results concerni
ng this serpin-protease pair, as well as for results obtained with oth
er such pairs. Incubation of rACT and Chtr leads rapidly to the format
ion-of an inhibited complex, Chtr.rACT, that is stable toward sodium
dodecyl sulfate denaturation and boiling. The extent of release of act
ive Chtr from this complex increases markedly as ionic strength, mu, i
s raised. The kinetic scheme quantitatively accounts for this effect o
n the basis of a partitioning of Chtr.rACT between dissociation of th
e complex to yield active enzyme and cleaved rACT, and Chtr.catalyzed
conversion of the complex to a form that is much more resistant to rel
ease of active enzyme. Sodium dodecyl sulfate-polyacrylamide gel elect
rophoresis analyses of reaction mixtures of rACT and Chtr are consiste
nt with the scheme. Also consistent are the results of experiments mea
suring the effects of 1) Chtr.rACT concentration, 2) uncomplexed Chtr
, and 3) added alpha2-Macroglobulin on active Chtr release from Chtr.r
ACT. Proteolysis of Chtr.rACT* to give a resistant complex is also ca
talyzed by human neutrophil elastase, a process with potential physiol
ogical relevance. Comparison of the rates of Chtr dissociation from th
e complexes formed with rACT and with rACT variants mutated at the P1
site suggests that such rates are more sensitive to P1 substitution at
low mu than at high mu. Several equivalents of the L358R-rACT variant
are required for full inhibition of Chtr. This observation is also qu
antitatively accounted for by the proposed kinetic scheme, on the basi
s of another partitioning step between L358R-rACT acting as a substrat
e or as an inhibitor toward Chtr.